Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already signal read-only, open-world, idempotent, and non-destructive behavior; the description adds substantial meaningful context on top: multiple internal lookups, graceful degradation when GLEIF/OpenFIGI are unavailable, explicit `unresolved` fields, `figi_candidates` for ambiguous matches, source-labelled identifiers, and ownership data when available. This goes well beyond structured fields.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, with many nested parenthetical clauses, but it is front-loaded with examples and scoping, and every cluster adds necessary behavior for a complex tool. It could be better organized with bullets or shorter sentences, but it earns most of its length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description covers what the tool returns for each type, how ambiguity is handled, what happens on partial enrichment failure, what inputs are accepted, and how to phrase names. It also explains the internal cascade so an agent understands the cost and value of the call. This is unusually complete for a tool with no structured output schema.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description still adds significant value beyond the schema. It explains what `type: company` resolves (CIK, ticker, LEI, FIGI, ownership), what `type: drug` resolves (RxCUI, ingredient, brand), and gives precise `value` guidance including negative examples like 'NEW YORK ST DORM AUTH' vs 'NEW YORK ST DORM AUTH revenue bonds'.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete natural-language triggers, then states a specific verb and resource: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require.' This clearly distinguishes it from siblings like entity_profile and compare_entities: this tool is specifically about getting identifiers from names, not building profiles or comparing entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit usage directive: 'Use FIRST whenever you have a name but need an ID.' It also clarifies that an ISIN resolves to the issuing legal entity, that non-equity instruments resolve, and warns against passing full noun phrases for bonds. It does not explicitly name alternatives to use instead in specific cases, but the 'when to use' guidance is strong and unambiguous.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation3/5

Several tools have clear functional boundaries, but there is meaningful overlap at the top level: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded share one routing pipeline, and ask_pipeworx_beta is currently identical to ask_pipeworx. The six polymarket_* tools also form a dense family where an agent must read long descriptions to distinguish arbitrage scanning from edge detection from fill-risk evaluation.

Naming Consistency4/5

Names are uniformly lowercase snake_case and mostly follow verb_noun or domain-prefix conventions, which makes the set much more predictable than its count suggests. Minor deviations exist: ask_pipeworx variants are product-noun phrases, polymarket_edges is a noun phrase rather than a verb-led tool, and pairs like polymarket_edges vs polymarket_edge_tracker are easy to misread.

Tool Count2/5

With 31 tools, this server is above the 25+ threshold and feels overloaded for a single MCP surface. It mixes broad data research, prediction-market analysis, memory, subscriptions, feedback, and niche utilities like generate_llms_txt, so the set is more like several related servers merged together.

Completeness4/5

The core workflow is well covered: discovery, single-answer routing, grounded verification, deep research, entity resolution, comparison, change tracking, subscription lifecycle, and even memory primitives. Missing are minor lifecycle refinements such as updating an existing subscription, and the number of overlapping entry points makes it slightly harder to guarantee the agent will always choose the intended path.